GLP-1 maintenance refers to the adjusted, lower-dose phase of GLP-1 medication use after a patient has reached or is close to their goal weight
The chemical ingredients include Secoiritoid glycosides, amarogentin, and gentiopicrin, which are responsible for the bitter flavor
It also has beneficial effects on fasting insulin and lipid metabolism
The present invention provides methods of, and uses in, preferentially or specifically inhibiting VEGF binding to the VEGF receptor VEGFR2, which generally comprise contacting, in the presence of VEGF, a population of cells or tissues that includes endothelial cells that express VEGFR2 (KDR/Flk-1) with a composition comprising a biologically effective amount of at least a first VEGFR2 -blocking, human anti-VEGF antibody of the invention, or an antigen-binding fragment thereof, under conditions effective to inhibit VEGF binding to the VEGF receptor VEGFR2